FXR
Il recettore X per il farnesoide (FXR) è un recettore nucleare che svolge un ruolo chiave nella regolazione dell'omeostasi degli acidi biliari, del metabolismo lipidico e della regolazione del glucosio. FXR è un potenziale bersaglio terapeutico per il trattamento di malattie epatiche, disturbi metabolici e malattie cardiovascolari. Gli inibitori di FXR possono modulare queste vie, offrendo approfondimenti sui meccanismi delle malattie e sulle strategie terapeutiche. Presso CymitQuimica, offriamo una gamma di inibitori di FXR per supportare la tua ricerca in epatologia, metabolismo e sviluppo di farmaci.
Trovati 62 prodotti di "FXR"
Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Fexarine
CAS:Fexarine is a potent, selective agonist of farnesoid X receptor.Formula:C31H31NO5Colore e forma:SolidPeso molecolare:497.58ST-1892
CAS:ST-1892 is a soluble partial FXR agonist.Formula:C16H12N2O3Purezza:98%Colore e forma:SolidPeso molecolare:280.28LY367385
CAS:LY367385 is a highly effective and selective mGluR1a antagonist.Formula:C10H11NO4Purezza:98%Colore e forma:SolidPeso molecolare:209.2HPG1860
CAS:HPG1860, an agonist of the farnesoid X receptor (FXR), induces luminescence in reporter gene assays utilizing HEK293T cells expressing human FXR, with an EC50 value of 18 nM. In vivo studies demonstrate that HPG1860 (administered at 1, 3, or 10 mg/kg daily) reduces serum alanine aminotransferase (ALT) and total cholesterol levels in a mouse model of non-alcoholic steatohepatitis (NASH), which was induced by a high-fat diet and carbon tetrachloride (CCl4). Additionally, this compound decreases hepatic inflammation, fat levels, and fibrosis.Formula:C27H26Cl2N4O4SColore e forma:SolidPeso molecolare:573.49FXR agonist 4
FXR agonist 4: EC50 of 1.05μM, treats hyperlipidemia, steatosis, insulin resistance, inflammation in DIO mice, for NAFLD research.Formula:C21H28ClN3OColore e forma:SolidPeso molecolare:373.92PX20606
CAS:PX20606 is an orally active farnesoid X receptor (FXR) agonist, demonstrating EC50 values of 220 nM (mFXR) and 50 nM (hFXR) in Gal4-FXR assays. It induces the expression of the tumor suppressor gene NDRG2 and inhibits tumor growth and metastasis in a mouse HCC model. Additionally, PX20606 exhibits hepatoprotective properties.
Formula:C29H22Cl3NO4Colore e forma:SolidPeso molecolare:554.85EDP-305
CAS:EDP-305, an oral FXR agonist, has EC50s of 34 nM/8 nM in CHO/HEK cells, aids in PBC and NASH research with antifibrotic properties.Formula:C36H58N2O5SColore e forma:SolidPeso molecolare:630.92BMS-986318
CAS:BMS-986318: potent FXR agonist, EC50=53/350 nM, good ADME, effective in liver disease models, for nonalcoholic steatohepatitis research.Formula:C30H23Cl2F3N4O3Colore e forma:SolidPeso molecolare:615.43GSK2324
CAS:GSK2324 is a potent FXR agonist for the treatment of NAFLD by controlling hepatic lipids through reduced uptake and selective reduction of fatty acid synthesis.Formula:C29H22Cl2N2O4Purezza:98.09% - 99.02%Colore e forma:SolidPeso molecolare:533.4FXR antagonist 1
CAS:"Oral FXR antagonist 1 selectively blocks intestinal FXR, with IC50 of 2.1 μM, aiding in NASH research by improving liver health."Formula:C36H59NO5Colore e forma:SolidPeso molecolare:585.86Chenodeoxycholic Acid 24-Acyl-β-D-Glucuronide
CAS:Chenodeoxycholic acid 24-acyl-β-D-glucuronide (CDCA-24G), a metabolite of CDCA, is synthesized from CDCA via the action of the UDP-glucuronosyltransferase (UG UT) isoform UGT1A3.Formula:C30H48O10Colore e forma:SolidPeso molecolare:568.7Chenodeoxycholic Acid 3-Glucuronide
CAS:Chenodeoxycholic acid 3-glucuronide (CDCA-3G), a metabolite of Chenodeoxycholic acid (CDCA), is synthesized in human liver microsomes.Formula:C30H48O10Colore e forma:SolidPeso molecolare:568.7GSK-8062
CAS:GSK-8062 is an agonist of farnesoid X receptor (FXR).Formula:C30H23Cl2NO4Purezza:98%Colore e forma:SolidPeso molecolare:532.41Omesdafexor
CAS:Omesdafexor is an FXR agonist that can be used to study diseases caused by liver disease or metabolic inflammation.Formula:C34H43N3O3Colore e forma:SolidPeso molecolare:541.72Lecufexor
CAS:Lecufexor is an agonist of the farnesoid X receptor (FXR).Formula:C32H21Cl3N2O5Colore e forma:SolidPeso molecolare:619.88BAR-2227
CAS:BAR-2227 (compound 3a) functions as an FXR agonist and a LIFR inhibitor. It is utilized in the study of liver fibrosis and inflammation.Formula:C24H17Cl2NO4Colore e forma:SolidPeso molecolare:454.30BMS-986339
CAS:BMS-986339: oral, potent FXR agonist; binds to His298/ASN287; for PBC, PSC, NASH, anti-fibrosis research.Formula:C35H41F4N3O4Colore e forma:SolidPeso molecolare:643.71Danifexor
CAS:Danifexor is an agonist of the farnesoid X receptor (Farnesoid X receptor).Formula:C29H20Cl2N2O5Colore e forma:SolidPeso molecolare:547.386FXR agonist 12
CAS:FXR agonist12 (Compound C7) is an orally active FXR agonist. It downregulates bile acid synthesis-related genes and upregulates bile acid transport-related genes in HepG2 cells. FXR agonist12 alleviates ANIT-induced cholestasis and reduces liver damage and fibrosis in a mouse model of NASH.
Formula:C26H44O3Colore e forma:SolidPeso molecolare:404.626FXR agonist 9
CAS:FXR agonist9 (compound 26) is a selective, orally active partial agonist of FXR with an EC50 of 0.09 µM (maximum efficacy of 75.13%). It ameliorates the pathological features of fatty liver disease in mice induced by HFD and CCl4-related metabolic dysfunction.Formula:C28H30N2O5Colore e forma:SolidPeso molecolare:474.55
